Shire and Takeda agree £46 billion takeover deal
The board of FTSE 100 drug firm Shire (LON:SHP) has recommended that shareholders accept Takeda’s takeover bid. The offer of $33.03 in cash and 0.839 New Takeda shares values the company at approximately £46 billion. The Dublin-based outfit had received five prior offers since March from its Japanese rival. Shire management rejected the prior bids…